Otuska ASD with irritability trial
NCT: 04174365
More information about the Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04174365?term=NCT%3A+04174365&draw=2&rank=1
Jansen TRD4005
NCT:04599855
More information about the Esketamine Nasal Spray study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04599855?term=NCT%3A04599855&draw=2&rank=1
Janssen MDD3001
NCT:04532749
More information about the Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04532749?term=NCT%3A04532749&draw=2&rank=1
Otsuka: 331-201-00072
NCT04124614
More information about the Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSDstudy can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04124614?term=NCT04124614&draw=2&rank=1
Biohaven BHV 4157-302
NCT04693351
More information about the Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04693351?term=NCT04693351&draw=2&rank=1
Neurocrine MDD2020
NCT05165394
More information about the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD (TERPSIS) study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT05165394?term=NCT05165394&draw=2&rank=1
Gw research GWND19189
NCT04745026
More information about the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04745026?term=NCT04745026&draw=2&rank=1
Supernus 812P412
NCT04786990
More information about the SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT04786990?term=NCT04786990&draw=2&rank=1
Otsuka 405-201-00016
NCT05257265
More information about the Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder study can be found at the link below
https://clinicaltrials.gov/ct2/show/NCT05257265?term=NCT05257265&draw=2&rank=1